PRIA Logo™

The hidden hand

The tobacco plant healing human wounds

CollPlant engineers transgenic tobacco to produce recombinant human collagen, the protein that comprises 30% of the human body.

The number

30% of human body composition

The same plant engineered to cause cancer is now being modified to grow structurally identical Type I collagen with zero prion risk and no animal allergens. CollPlant's recombinant approach bypasses religious compliance issues while scaling toward commercial medical device volumes.

Source: CollPlant Engineers Tobacco Plants to Produce Human Collagen · Labiotech · Jan 1, 2024

Jump into the supply map

Where this story connects

The supplymap lets you trace the goods, inputs, and companies this story touches, see the full dependency chain, country shares, and historical incidents.

More on Supply input · Medical-Grade Atelocollagen (Wound Care / Bone Regeneration / Device OEM)

Related stories